SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Case report

SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity

Online download statistics by month:

Online download statistics by month: July 2020 to May 2023

	Abstract	Full	Pdf
Jul 2020	126	126	37
Aug 2020	455	452	323
Sep 2020	304	304	209
Oct 2020	261	262	106
Nov 2020	180	179	73
Dec 2020	238	238	84
Jan 2021	287	288	129
Feb 2021	313	313	79
Mar 2021	338	338	84
Apr 2021	207	207	59
May 2021	221	221	65
Jun 2021	128	128	55
Jul 2021	92	93	53
Aug 2021	87	88	53
Sep 2021	81	81	50
Oct 2021	143	143	69
Nov 2021	90	88	54
Dec 2021	95	101	41
Jan 2022	90	91	39
Feb 2022	71	78	43
Mar 2022	70	75	36
Apr 2022	74	77	26
May 2022	79	81	44
Jun 2022	98	101	35
Jul 2022	262	264	22
Aug 2022	85	87	43
Sep 2022	56	56	20
Oct 2022	51	59	29
Nov 2022	45	45	19
Dec 2022	48	48	14
Jan 2023	39	39	17
Feb 2023	80	80	20
Mar 2023	58	59	27
Apr 2023	27	27	24
May 2023	28	28	12
Total	4907	4945	2093